Related Experiment Videos
Behçet syndrome: report of two early-onset cases treated with transfer factor
Italian Journal of Neurological Sciences
|March 1, 1984
Insights
Transfer factor treatment shows promise for children with Behçet syndrome, a rare inflammatory condition. This therapy was effective in two pediatric cases with severe neurological and ocular symptoms when other treatments failed.
Area of Science:
- Pediatric Rheumatology
- Immunology
- Neuro-inflammatory Diseases
Background:
- Behçet syndrome is a rare multisystem inflammatory disorder.
- Pediatric cases often present with severe manifestations, including neurological and ocular involvement.
- Standard treatments can be ineffective for some patients.
Observation:
- Two children diagnosed with Behçet syndrome were studied.
- One child presented with neuro-Behçet syndrome features.
- The other child exhibited severe ocular complications.
Findings:
- Both patients received transfer factor therapy after conventional treatments failed.
- Transfer factor treatment demonstrated value in managing Behçet syndrome in these pediatric cases.
- The treatment's efficacy is observed over several years of ongoing therapy.
Implications:
- Transfer factor may represent a viable therapeutic option for refractory pediatric Behçet syndrome.
- Further research into transfer factor's role in autoimmune and inflammatory conditions is warranted.
- This study highlights potential new avenues for managing severe pediatric Behçet syndrome.
Abstract:
Report of two cases of Behçet syndrome in children, one with the features of a neuro-Behçet syndrome and the other with chiefly severe ocular changes. Both children were treated with transfer factor when previous treatment had proved ineffective. Some years after the beginning of treatment, which is still continuing, transfer factor may be said to be of value in Behçet syndrome.